Angiotensin II AT1 receptor blockade normalizes CD11b+ monocyte production in bone marrow of hypercholesterolemic monkeys

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 624-632

  Strawn, William B ^a   Ferrario, Carlos M ^a  

^a WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Angiotensin; CD34; Hematopoiesis; Hematopoietic stem cell; Hypercholesterolemia; LDL; Monocyte

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CD11B ANTIGEN; CD34 ANTIGEN; LOSARTAN; LOW DENSITY LIPOPROTEIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD; BONE MARROW; CD34 SELECTION; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; HEMATOPOIETIC STEM CELL; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; MONKEY; MONOCYTE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CHOLESTEROL INTAKE; DRUG EFFECT; MACACA; METABOLISM; MONONUCLEAR CELL; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; ANTIGENS, CD11B; ANTIGENS, CD34; BONE MARROW CELLS; CHOLESTEROL; CHOLESTEROL, DIETARY; HYPERCHOLESTEROLEMIA; LEUKOCYTES, MONONUCLEAR; LOSARTAN; MACACA FASCICULARIS; MALE; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 38349175636     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.024     Document Type: Article

References (30)

1. Weber C., Erl W., Weber K.S., and Weber P.C. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol 30 (1997) 1212-1217
2. Strehlow K., Wassmann S., Bohm M., and Nickenig G. Angiotensin AT1 receptor over-expression in hypercholesterolaemia. Ann Med 32 (2000) 386-389
3. Mateo T., bu Nabah Y.N., Abu T.M., et al. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 176 (2006) 5577-5586
4. Khan B.V., Navalkar S., Khan Q.A., Rahman S.T., and Parthasarathy S. Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease. J Am Coll Cardiol 38 (2001) 1662-1667
5. Strawn W.B., Chappell M.C., Dean R.H., Kivlighn S., and Ferrario C.M. Inhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolemia. Circulation 101 (2000) 1586-1593
6. Cassis L.A., Rateri D.L., Lu H., and Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 27 (2007) 380-386
7. Nishida M., Fujinaka H., Matsusaka T., et al. Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 110 (2002) 1859-1868
8. Rodgers K.E., Xiong S., Steer R., and diZerega G.S. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells 18 (2000) 287-294
9. Averill L.E., Meagher R.C., and Gerrity R.G. Enhanced monocyte progenitor cell proliferation in bone marrow of hyperlipemic swine. Am J Pathol 135 (1989) 369-377
10. Feldman D.L., Mogelesky T.C., Liptak B.F., and Gerrity R.G. Leukocytosis in rabbits with diet-induced atherosclerosis. Arterioscler Thromb 11 (1991) 985-994
11. Nickenig G., Wassmann S., and Bohm M. Regulation of the angiotensin AT1 receptor by hypercholesterolaemia. Diabetes Obes Metab 2 (2000) 223-228
12. John S., Delles C., Klingbeil A.U., et al. Low-density lipoprotein-cholesterol determines vascular responsiveness to angiotensin II in normocholesterolaemic humans. J Hypertens 17 (1999) 1933-1939
13. Nickenig G., Sachinidis A., Michaelsen F., et al. Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation 95 (1997) 473-478
14. Ettinger W.H., Dysko R.C., and Clarkson T.B. Prednisone increases low density lipoprotein in cynomolgus monkeys fed saturated fat and cholesterol. Arteriosclerosis 9 (1989) 848-855
15. Yasar U., Forslund-Bergengren C., Tybring G., et al. Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype. Clin Pharmacol Ther 71 (2002) 89-98
16. Shibata H., Hanazono Y., Ageyama N., et al. Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies. Am J Primatol 61 (2003) 3-12
17. Duvillard L., Florentin E., Lizard G., et al. Cell surface expression of LDL receptor is decreased in type 2 diabetic patients and is normalized by insulin therapy. Diabetes Care 26 (2003) 1540-1544
18. Rasini E., Cosentino M., Marino F., et al. Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept 134 (2006) 69-74
19. Drouet M., Mourcin F., Grenier N., et al. Single administration of stem cell factor, FLT-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression: long-term follow-up of hematopoiesis. Blood 103 (2004) 878-885
20. Kansas G.S., Muirhead M.J., and Dailey M.O. Expression of the CD11/CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76 (1990) 2483-2492
21. Winter S.S., Sweatman J.J., and Larson R.S. Improved quantification of cell survival on stromal monolayers by flow cytometric analyses. Cytometry 40 (2000) 26-31
22. Krizanac-Bengez L., Moore P.F., Barsoukov A., and Sandmaier B.M. The expression and differentiation pattern of cell antigens and adhesion molecules on the nonadherent cell population in canine long-term marrow culture: a biphasic development of myeloid and lymphoid cells. Tissue Antigens 51 (1998) 141-155
23. Poumay Y., and Ronveaux-Dupal M.F. Rapid preparative isolation of concentrated low density lipoproteins and of lipoprotein-deficient serum using vertical rotor gradient ultracentrifugation. J Lipid Res 26 (1985) 1476-1480
24. Han K.H., Chen Y., Chang M.K., et al. LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes. J Lipid Res 44 (2003) 1332-1340
25. Miyazaki M., and Takai S. Anti-atherosclerotic efficacy of olmesartan. J Hum Hypertens 16 Suppl 2 (2002) S7-S12
26. Brunet dlG, Ivanovic Z., Leprivey-Lorgeot V., and Praloran V. Angiotensin II that reduces the colony-forming ability of hematopoietic progenitors in serum free medium has an inverse effect in serum-supplemented medium. Stem Cells 20 (2002) 269-271
27. Aye M.T., Seguin J.A., and McBurney J.P. Erythroid and granulocytic colony growth in cultures supplemented with human serum lipoproteins. J Cell Physiol 99 (1979) 233-238
28. Strawn W.B., Richmond R.S., Ann T.E., Gallagher P.E., and Ferrario C.M. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol 126 (2004) 120-126
29. Sinha A.K., and Mehta J.L. Modulation of atherosclerosis, blood pressure and arterial elasticity by statins. Adv Cardiol 44 (2007) 315-330
30. Nickenig G., Baumer A.T., Temur Y., et al. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 100 (1999) 2131-2134